A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection

AIDS. 2005 Oct:19 Suppl 3:S53-63. doi: 10.1097/01.aids.0000192071.72948.77.

Abstract

Numerous studies have reported associations between chronic hepatitis C virus (HCV) infection and fatigue, depression and impairments in health-related quality of life, which are independent of the severity of liver disease. Although there are a large number of potential explanations for these symptoms, including a history of substance abuse and associated personality types, or the effect of the diagnosis of HCV infection itself, there has been recent interest in the possibility of a biological effect of HCV infection on cerebral function. There is emerging evidence of mild, but significant neurocognitive impairment in HCV infection, which cannot be wholly attributed to substance abuse, co-existent depression or hepatic encephalopathy. Impairments are predominantly in the domains of attention, concentration and information processing speed. Furthermore, in-vivo cerebral magnetic resonance spectroscopy studies in patients with hepatitis C and normal liver function have reported elevations in cerebral choline-containing compounds and reductions in N-acetyl aspartate, suggesting that a biological mechanism may underlie the cognitive findings. The recent detection of HCV genetic sequences in post-mortem brain tissue raises the intriguing possibility that HCV infection of the central nervous system may be related to the reported neuropsychological symptoms and cognitive impairment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Brain / metabolism*
  • Cognition Disorders / virology*
  • Depression / virology
  • Fatigue / virology
  • HIV Infections / psychology
  • Hepatitis C, Chronic / metabolism
  • Hepatitis C, Chronic / psychology*
  • Humans
  • Magnetic Resonance Spectroscopy
  • Quality of Life